Prevention of Hepatitis B Reactivation in Patients Receiving Immunosuppressive Therapy: a Case Series and Appraisal of Society Guidelines

Hepatitis B (HBV) reactivation (HBVr) is a potentially fatal complication in patients with past HBV exposure receiving immunosuppressive therapy. HBVr can occur in patients with chronic HBV infection as well as in patients with resolved HBV infection. In this article, we present the cases of four pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Etienne, Samuel, Vosbeck, Jürg, Bernsmeier, Christine, Osthoff, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Narrative Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905451/
https://www.ncbi.nlm.nih.gov/pubmed/36138278
http://dx.doi.org/10.1007/s11606-022-07806-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9905451/
https://www.ncbi.nlm.nih.gov/pubmed/36138278
http://dx.doi.org/10.1007/s11606-022-07806-9

Ejemplares similares